Cat.#: ACPP-1636
Despition | Vasopressin |
SIZE | 5 mg |
Sequence | C[Cys-Tyr-Phe-Gln-Asn-Cys]-Pro-Arg-Gly-NH2. |
Purity | > 98.0% (SDS-PAGE) |
Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored and desiccated below -18°C. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1402 | Mouse CDNF Protein (AC1402) | 5 µg | inquiry |
ACPP-1628 | Human LIF Protein, GST (AC1628) | 2 µg | inquiry |
ACPP-1085 | Recombinant Human alpha Internexin Protein (AC1085) | 25 µl | inquiry |
ACPP-1251 | EAAT2 Blocking Peptide (AC1251) | 250 µg | inquiry |
ACPP-1695 | Human LGALS9 Protein (AC1695) | 2 µg | inquiry |
ACPP-1263 | MAPK7 Blocking Peptide (AC1263) | 250 µg | inquiry |
ACPP-1557 | Human TARDBP Protein (AC1557) | 2 µg | inquiry |
ACPP-1203 | ADCY8 Blocking Peptide (AC1203) | 250 µg | inquiry |
ACPP-1707 | Human RAB5B Protein (AC1707) | 5 µg | inquiry |
ACPP-1759 | Rat CDNF Protein (AC1759) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.